Eden Research plc Result of GM and Capital Raising update (6395J)

TIDMEDEN

RNS Number : 6395J

Eden Research plc

17 August 2023

17 August 2023

Eden Research

("Eden" or "the Company")

Result of General Meeting and Capital Raising update

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, is pleased to announce that all resolutions put forward to shareholders at the Company's General Meeting held earlier today were duly passed.

The total number of votes received by proxy on each resolution, as more fully disclosed in the Notice of Meeting available on the Company's website, was as follows:

 
             Resolution              For         %     Against    %     Withheld 
  # 
      Grant authority to 
       the Directors to allot 
 1     Ordinary Shares           129,273,794   99.79   269,322   0.21    13,950 
     -------------------------  ------------  ------  --------  -----  --------- 
      Disapply statutory 
       pre-emption rights 
 2     on allotment of shares*   129,183,794   99.72   359,322   0.28    13,950 
     -------------------------  ------------  ------  --------  -----  --------- 
      Grant authority to 
       cancel share premium 
 3     account*                  129,157,112   99.76   316,252   0.24    83,702 
     -------------------------  ------------  ------  --------  -----  --------- 
 

Notes:

   --    * Denotes a Special Resolution. 

-- A vote Withheld is not a vote in law and is not counted in the calculation of the votes cast For or Against the resolution, nor in the calculation of the percentage of issued share capital voted for any resolution.

-- Votes For and Against are expressed as a percentage of votes validly cast for that resolution by proxy, excluding any Withheld votes.

Capital Raising update

In the announcement made by the Company on 28 July 2023 regarding its Capital Raising, it was stated that "The Placing of the Conditional Placing Shares is conditional, inter alia, on (i) the approval of the Resolutions at the General Meeting, (ii) the Advanced Assurance being obtained from HMRC, (iii) the Capital Reduction becoming effective and (iv) Second Admission."

In addition to the Resolutions having been approved at the General Meeting today, the Company is pleased to confirm that it has also obtained the Advanced Assurance from HMRC required for the Conditional Placing.

The expected timetable for the satisfying the remaining conditions of the Conditional Placing is as follows:

 
 Expected date for final hearing    12 September 
  and confirmation of the Capital 
  Reduction by the Court 
 Expected date that the Capital     14 September 
  Reduction become effective 
                                   ---------------------------------- 
 Second Admission                   Expected second half of September 
                                   ---------------------------------- 
 Second Admission Long Stop Date    8 a.m. on 20 October 
                                   ---------------------------------- 
 

For further information contact:

 
 Eden Research plc                                www.edenresearch.com 
 Sean Smith 
  Alex Abrey                                             01285 359 555 
 
 Cenkos Securities plc (Nominated advisor 
  and broker) 
 Giles Balleny / Max Gould (corporate 
  finance) 
  Michael Johnson (sales)                                020 7397 8900 
 
 Hawthorn Advisors (Financial PR) 
 Simon Woods                                 [e-mail] 
  Felix Meston 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMGIGDIUDBDGXR

(END) Dow Jones Newswires

August 17, 2023 04:27 ET (08:27 GMT)